Supercritical solvent impregnation of piroxicam on PVP at various polymer molecular weights

Journal of Supercritical Fluids

Volumn 49, Issue 2, 2009, Pages 271-278

  Banchero, Mauro ^a   Manna, Luigi ^a   Ronchetti, Silvia ^a   Campanelli, Pasquale ^a   Ferri, Ada ^a  

^a POLITECNICO DI TORINO   (Italy)

Author keywords

Drug release; Fourier transformed infrared spectroscopy; Piroxicam; Powder impregnation; PVP; X ray powder diffraction

Indexed keywords

ANTI-INFLAMMATORY DRUGS; AQUEOUS SOLUTIONS; CHAIN POLYMERS; DISSOLUTION RATES; DRUG CONTENTS; DRUG CRYSTALS; DRUG DISSOLUTIONS; DRUG RELEASE; FOURIER-TRANSFORM; FOURIER-TRANSFORMED INFRARED SPECTROSCOPY; FTIR; IN-VITRO; KINETICS OF RELEASE; MATRIXES; PHYSICAL MIXTURES; PHYSICAL STATE; PIROXICAM; POLYMER MOLECULAR WEIGHTS; POLYVINYL-PYRROLIDONE; PURE COMPONENTS; PVP; SUPER-CRITICAL; SUPERCRITICAL CO; SUPERCRITICAL SOLVENT IMPREGNATIONS; X- RAY DIFFRACTIONS;

ACTIVE NETWORKS; DIFFRACTION; DISSOLUTION; DRUG PRODUCTS; EFFLUENT TREATMENT; FOURIER TRANSFORM INFRARED SPECTROSCOPY; FOURIER TRANSFORMS; IMPREGNATION; MOLECULAR INTERACTIONS; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; POLYMERS; POWDERS; PYRIDINE; SODIUM COMPOUNDS; SPECTROSCOPIC ANALYSIS; SPECTRUM ANALYSIS; X RAY POWDER DIFFRACTION;

DRUG INTERACTIONS;

EID: 67349252282     PISSN: 08968446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.supflu.2009.01.008     Document Type: Article

References (23)

1. Löbenberg R., and Amidon G.L. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur. J. Pharm. Biopharm. 50 (2000) 3-21
2. Leuner C., and Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 50 (2000) 47-60
3. Takeuchi H., Yasuji T., Hino T., Yamamoto H., and Kawashima Y. Spray-dried composite particles of lactose and sodium alginate for direct tabletting and controlled release. Int. J. Pharm. 174 (1998) 91-100
4. Tantishaiyakul V., Kaewnopparat N., and Ingkatawornwong S. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone K-30. Int. J. Pharm. 143 (1996) 59-66
5. Tantishaiyakul V., Kaewnopparat N., and Ingkatawornwong S. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone. Int. J. Pharm. 181 (1999) 143-151
6. Betageri G.V., and Makarla K.R. Enhancement of dissolution of glyburide by solid dispersion and lyophilization techniques. Int. J. Pharm. 126 (1995) 155-160
7. Tandya A., Mammucari R., Dehghani F.N., and Foster R. Dense gas processing of polymeric controlled release formulations. Int. J. Pharm. 328 (2007) 1-11
8. Clifford T. Fundamentals of Supercritical Fluids (1999), Oxford University Press, New York
9. Guney O., and Akgerman A. Synthesis of controlled-release products in supercritical medium. AIChE J. 48 (2002) 856-866
10. Duarte A.R.C., Costa M.S., Simplicio A.L., Cardoso M.M., and Duarte C.M.M. Preparation of controlled release microspheres using supercritical fluid technology for delivery of anti-inflammatory drugs. Int. J. Pharm. 308 (2006) 168-174
11. Alessi P., Kikic I., Cortesi A., Fogar A., and Moneghini M. Polydimethylsiloxanes in supercritical solvent impregnation (SSI) of polymers. J. Supercrit. Fluids 27 (2003) 309-315
12. Argemi A., Lopez-Periago A., Domingo C., and Saurina J. Spectroscopic and chromatographic characterization of triflusal delivery systems prepared by using supercritical impregnation technologies. J. Pharm. Biomed. Anal. 46 (2008) 456-462
13. Sethia S., and Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int. J. Pharm. 272 (2004) 1-10
14. Kazarian S.G., and Martirosyan G.G. Spectroscopy of polymer/drug formulations processed with supercritical fluids: in situ ATR-IR and Raman study of impregnation of ibuprofen into PVP. Int. J. Pharm. 232 (2002) 81-90
15. 2. J. Supercrit. Fluids 42 (2007) 378-384
16. Vrečer F., Vrbinc M., and Meden A. Characterization of piroxicam crystal modifications. Int. J. Pharm. 256 (2003) 3-15
17. Zhang G.G.Z., Law D., Schmitt E.A., and Qiu Y. Phase transformation during process development and manufacture of solid oral dosage forms. Adv. Drug Deliv. Rev. 56 (2004) 371-390
18. Pasquali I., Bettini R., and Giordano F. Supercritical fluid technologies: an innovative approach for manipulating the solid-state of pharmaceuticals. Adv. Drug Deliv. Rev. 60 (2008) 399-410
19. Bettini R., Bonassi L., Castoro V., Rossi A., Zerma L., Gazzaniga A., and Giordano F. Solubility and conversion of carbamazepine polymorphs in supercritical carbon dioxide. Eur. J. Pharm. Sci. 13 (2001) 281-286
20. Tozuka Y., Kawada D., Oguchi T., and Yamamoto K. Supercritical carbon dioxide treatment as a method for polymorph preparation of deoxycholic acid. Int. J. Pharm. 263 (2003) 45-50
21. Sheth A.R., Lubach J.W., Munson E.J., Muller F.X., and Grant D.J.W. Mechanochromism of piroxicam accompanied by intermolecular proton transfer probed by spectroscopic methods and solid-phase changes. J. Am. Chem. Soc. 127 (2005) 6641-6651
22. Shakhtshneider T.P., Danede F., Capet F., Willart J.F., Descamps M., Myz S.A., Boldyreva E.V., and Boldyrev V.V. Grinding of drugs with pharmaceutical excipients at cryogenic temperatures. J. Therm. Anal. Calorim. 89 (2007) 699-707
23. Albertini B., Cavallari C., Passerini N., Gonzalez-Rodriguez M.L., and Rodriguezs L. Evaluation of β-lactose, PVP K12 and PVP K90 as excipients to prepare piroxicam granules using two wet granulation techniques. Eur. J. Pharm. Biopharm. 56 (2003) 479-487